GLP-1 agonists , or glucagon-like peptide-1 compounds , are showing as a remarkable breakthrough in addressing hyperglycemia. These novel therapies work by stimulating insulin production and inhibiting https://glp1246037.blog-gold.com/59837075/glp-1-a-promising-strategy-in-glucose-management